What they had in common was an extensive profile of symptoms that prevented them from thriving. They reported difficulties sleeping, feeling "tired but wired," being stuck in hypervigilance, and struggling in their relationships. Some avoided going out in public or found it hard to function “normally.” Tasks the rest of us take for granted as easy—like holding a glass of water or going to the grocery store—felt daunting or impossible for patients whose nervous systems were locked in overdrive. Their experiences affected their ability to trust, connect, stay calm, or be patient with others.
In the privacy of her clinic, she had first hand experience observing Counterstrain’s ability to profoundly improve the physical and emotional well-being of people recovering from complex trauma. Patients often felt as if they were getting their lives back and reported experiencing relief and hope for the first time in many, many years.
However, Dr. Christy knew that heartwarming stories alone wouldn’t be enough to build the awareness needed to make a large-scale impact and make Fascial Counterstrain accessible to the millions of people who could benefit from its healing potential.
She needed data.
The practitioner-research team spent more than 2 years developing and finalizing the ideas and protocol that would become Bridge Back Project’’s first clinical trial study, which ran from January 2020 to October 2021.
The goal was to answer the question: “Can Fascial Counterstrain effectively treat symptoms of posttraumatic stress disorder and its comorbidities?” The journey to publish research finding can often take years, and our paper is still undergoing peer review and editing. When our findings are finally published, we will share what we’ve learned far and wide.